MAIA Biotechnology, Inc. (MAIA)
2025-06-30 | ||||
|---|---|---|---|---|
| Interest income | 79,697 | |||
| Change in fair value of warrant liability | 260,602 | |||
| Loss on fair value of warrants over proceeds | - | |||
| Australian research and development incentives | - | |||
| Other (expense) income, net | -180,905 | |||
| Research and development expenses | 3,110,867 | |||
| General and administrative expenses | 2,055,191 | |||
| Total operating expenses | 5,166,058 | |||
| Loss from operations | -5,166,058 | |||
| Net loss | -5,346,963 | |||
| Net loss per share - basic | -0.18 | |||
| Net loss per share - diluted | -0.18 | |||
| Weighted average common shares outstanding - basic | 30,300,339 | |||
| Weighted average common shares outstanding - diluted | 30,300,339 | |||